Instil Bio Announces U.S. F.D.A. Clearance of Investigational New Drug (IND) Application for AXN-2510, a PD-L1xVEGF Bispecific Antibody, for a Phase 1 Trial in Relapsed/Refractory Solid Tumors
July 02, 2025 06:00 ET Â | Source: Instil Bio US phase 1…
Captain Rahul Bali Curates First Ever Aizawl International Half Marathon in Mizoram
Internationally acclaimed Curator Captain Rahul Bali curated the first ever Aizawl International…
Kia America Posts Highest FirstHalf Sales in Company History
416,511 units sold in first six months of 2025, up 8 percent…
NYSE Content Advisory: Pre-Market update + NYSE led globally in total capital raised during first half of 2025
NEW YORK, July 1, 2025 /PRNewswire/ -- The New York Stock Exchange…
